Showing results (101-110 of 242) with videos related to
Sort By:
Pageof 25
The Lancet. Oncology|August 6, 2019
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trialMichael Friedlander, Tarek Meniawy, Ben Markman, et al.European Journal of Cancer (Oxford, England : 1990)|February 3, 2024
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trialVéronique Diéras, Hyo S Han, Hans Wildiers, et al.Asia-Pacific Journal of Clinical Oncology|July 26, 2022
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapyDavid Mizrahi, David Goldstein, Terry Trinh, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinomaJonathan A Ledermann, Daniela Luvero, Aaron Shafer, et al.Journal of Experimental & Clinical Cancer Research : CR|December 20, 2022
CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitorsXue Lu, Yaowu He, Rebecca L Johnston, et al.Translational Oncology|February 28, 2024
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trialBonnita Werner, Katrin M Sjoquist, David Espinoza, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcomaFrédéric Amant, Anne Floquet, Michael Friedlander, et al.Journal of Gynecologic Oncology|July 23, 2019
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progressionPeey Sei Kok, Philip Beale, Rachel L O'Connell, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovaryNicholas Simon Reed, Eva Gomez-Garcia, Dolores Gallardo-Rincon, et al.BMC Cancer|July 31, 2012
How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancerKaaren J Watts, Bettina Meiser, Gillian Mitchell, et al.Pageof 25